Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl

EI Hasan, BI Amro, T Arafat, AA Badwan - European journal of …, 2003 - Elsevier
EI Hasan, BI Amro, T Arafat, AA Badwan
European journal of pharmaceutics and biopharmaceutics, 2003Elsevier
Metoclopramide HCl showed controlled release behavior when embedded in a hydrophilic
matrix of chitosan and sodium alginate. The in vitro release data was found to be first order
according to the Higuchi mechanism. An in vivo evaluation of the metoclopramide controlled
release matrix on six male volunteers was carried out. The plasma samples were analyzed
using a high-performance liquid chromatography (HPLC) method using a mobile phase of
acetonitrile: acetic acid (30: 70), with the pH adjusted to 4.7, a reverse phase Hypersil BDS …
Metoclopramide HCl showed controlled release behavior when embedded in a hydrophilic matrix of chitosan and sodium alginate. The in vitro release data was found to be first order according to the Higuchi mechanism. An in vivo evaluation of the metoclopramide controlled release matrix on six male volunteers was carried out. The plasma samples were analyzed using a high-performance liquid chromatography (HPLC) method using a mobile phase of acetonitrile:acetic acid (30:70), with the pH adjusted to 4.7, a reverse phase Hypersil BDS Phenyl column (4μm, 250×4mm) and the detection was performed at 305nm. The controlled release formula was found to be effective in delaying absorption (tmax 4.5h as compared to 1.2h), reducing the peak plasma concentrations (Cmax 63.4ng/ml as compared to 95.9ng/ml) and maintaining higher concentrations during the elimination phase when compared to the immediate release formula. This proves the suitability of the suggested system for further studies.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果